Li Ming, Song Baoying, Wu Yan, Zhang Yang, Cao Xiaofeng, Zhang Hongkang, Xu Yi, Wu Chuanjie, Li Chuanhui, Zhou Chen, Liu Lu, Yan Feng, Li Sijie, Chen Jian, Meng Ran, Duan Jiangang, Wu Di, Zuo Lin, Xu Zikai, Li Zhou, Zheng Yufeng, Jiang Miaowen, Ji Xunming
China-America Institute of Neuroscience and Beijing Institute of Geriatrics, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Department of Neurosurgery and Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Natl Sci Rev. 2025 Jan 14;12(3):nwaf015. doi: 10.1093/nsr/nwaf015. eCollection 2025 Mar.
Cerebral venous sinus thrombosis (CVST) is frequently observed in younger adults and features in large thrombus volume. Due to the triangular-like cross-sectional shape and large diameter of the superior sagittal sinus, all the commercially available artery stent retrievers are not suitable for venous vessels. In this study, a dumbbell-like stent was designed and fabricated by 3D braided technology using NiTi wires; it was manually rotatable and stretchable with controlled length/diameter ratios (2.6-14.0) and reciprocating maneuverability. Computational modeling and an study were conducted to evaluate the mechanical properties of this device and its ability to trap and remove thrombi from occluded venous vessels was verified by using a swine model. A single-center retrospective clinical study of 10 patients using the Venus-TD to treat patients with CVST was also conducted. Pre/postoperative thrombus volume in 10 patients was quantitatively analysed (12 855.3 ± 6417.1 vs. 2373.1 ± 2759.0 mm³, < 0.001) with a high recanalization rate, yielding favorable clinical outcomes. This study offers a novel treatment option for patients with extensive CVST.
脑静脉窦血栓形成(CVST)在年轻成年人中较为常见,其特点是血栓体积较大。由于上矢状窦呈三角形横截面形状且直径较大,所有市售的动脉支架取栓器都不适用于静脉血管。在本研究中,使用镍钛丝通过3D编织技术设计并制造了一种哑铃状支架;它可手动旋转和拉伸,具有可控的长度/直径比(2.6 - 14.0)和往复操作性。进行了计算建模和一项研究以评估该装置的力学性能,并通过猪模型验证了其从闭塞静脉血管中捕获和清除血栓的能力。还进行了一项单中心回顾性临床研究,对10例使用Venus - TD治疗CVST患者的情况进行了研究。对10例患者术前/术后的血栓体积进行了定量分析(12855.3±6417.1 vs. 2373.1±2759.0 mm³,<0.001),再通率高,临床结果良好。本研究为广泛CVST患者提供了一种新的治疗选择。